Castle Biosciences, Inc. Common Stock vs. Natera, Inc. Common Stock
CSTL
Castle Biosciences, Inc. Common Stock
$35.75 -2.80%
VS NTRANatera, Inc. Common Stock
$361.81 -1.23%
Castle Biosciences, Inc. Common Stock (CSTL) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| CSTL | NTRA | |
|---|---|---|
| Market Cap | $1.12 billion | $52.80 billion |
| Revenue (TTM) | $357.28 million | $2.71 billion |
| Net Income (TTM) | $-19,415,000 | $-192,346,000 |
NTRA leads on 2 of 3 size & scale factors.
Valuation
| CSTL | NTRA | |
|---|---|---|
| Price / Book | 2.39 | 28.99 |
| Price / Sales | 3.14 | 19.50 |
CSTL leads on 2 of 2 valuation factors.
Profitability
| CSTL | NTRA | |
|---|---|---|
| Net Margin | -5.43% | -7.11% |
| Return on Equity | -4.13% | -10.56% |
CSTL leads on 2 of 2 profitability factors.
Risk & Sentiment
| CSTL | NTRA | |
|---|---|---|
| Short Interest | 0.04% | 0.96% |
CSTL leads on 1 of 1 risk & sentiment factors.
Dig deeper: CSTL overview, CSTL financials, NTRA overview, NTRA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.